Lead sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
4
Trials led
2
Active
926
Total enrollment
99
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
2
Phase 3
2
Trials by status
Not yet recruiting
1
Recruiting
1
Completed
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 DiabetesBMI 18.5-45Ph 3Unknown424
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsBMI ≥28Ph 3Not yet recruiting408